468 related articles for article (PubMed ID: 27475884)
1. Role of histamine H4 receptor ligands in bleomycin-induced pulmonary fibrosis.
Lucarini L; Pini A; Rosa AC; Lanzi C; Durante M; Chazot PL; Krief S; Schreeb A; Stark H; Masini E
Pharmacol Res; 2016 Sep; 111():740-748. PubMed ID: 27475884
[TBL] [Abstract][Full Text] [Related]
2. Prevention of bleomycin-induced lung inflammation and fibrosis in mice by naproxen and JNJ7777120 treatment.
Rosa AC; Pini A; Lucarini L; Lanzi C; Veglia E; Thurmond RL; Stark H; Masini E
J Pharmacol Exp Ther; 2014 Nov; 351(2):308-16. PubMed ID: 25185215
[TBL] [Abstract][Full Text] [Related]
3. Histamine H4 receptor antagonism diminishes existing airway inflammation and dysfunction via modulation of Th2 cytokines.
Cowden JM; Riley JP; Ma JY; Thurmond RL; Dunford PJ
Respir Res; 2010 Jun; 11(1):86. PubMed ID: 20573261
[TBL] [Abstract][Full Text] [Related]
4. Effects of PARP-1 Deficiency and Histamine H
Durante M; Sgambellone S; Lanzi C; Nardini P; Pini A; Moroni F; Masini E; Lucarini L
Front Pharmacol; 2019; 10():525. PubMed ID: 31164820
[TBL] [Abstract][Full Text] [Related]
5. Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis.
Cicko S; Grimm M; Ayata K; Beckert J; Meyer A; Hossfeld M; Zissel G; Idzko M; Müller T
Respir Res; 2015 Sep; 16(1):105. PubMed ID: 26369416
[TBL] [Abstract][Full Text] [Related]
6. Prevention of bleomycin-induced lung fibrosis in mice by a novel approach of parallel inhibition of cyclooxygenase and nitric-oxide donation using NCX 466, a prototype cyclooxygenase inhibitor and nitric-oxide donor.
Pini A; Viappiani S; Bolla M; Masini E; Bani D
J Pharmacol Exp Ther; 2012 May; 341(2):493-9. PubMed ID: 22344408
[TBL] [Abstract][Full Text] [Related]
7. HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-β/SMAD signalling pathway.
Lucarini L; Durante M; Lanzi C; Pini A; Boccalini G; Calosi L; Moroni F; Masini E; Mannaioni G
J Cell Mol Med; 2017 Feb; 21(2):324-335. PubMed ID: 27704718
[TBL] [Abstract][Full Text] [Related]
8. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of functionally different histamine H
Adami M; Micheloni C; Grandi D; Stark H
Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1387-1397. PubMed ID: 30145688
[TBL] [Abstract][Full Text] [Related]
10. A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice.
Zhu Y; Liu Y; Zhou W; Xiang R; Jiang L; Huang K; Xiao Y; Guo Z; Gao J
Respir Res; 2010 Mar; 11(1):34. PubMed ID: 20302663
[TBL] [Abstract][Full Text] [Related]
11. Zingerone ameliorates oxidative stress and inflammation in bleomycin-induced pulmonary fibrosis: modulation of the expression of TGF-β1 and iNOS.
Gungor H; Ekici M; Onder Karayigit M; Turgut NH; Kara H; Arslanbas E
Naunyn Schmiedebergs Arch Pharmacol; 2020 Sep; 393(9):1659-1670. PubMed ID: 32377772
[TBL] [Abstract][Full Text] [Related]
12. Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung.
Lucattelli M; Fineschi S; Selvi E; Garcia Gonzalez E; Bartalesi B; De Cunto G; Lorenzini S; Galeazzi M; Lungarella G
Respir Res; 2016 May; 17(1):49. PubMed ID: 27153807
[TBL] [Abstract][Full Text] [Related]
13. Growth Hormone-Releasing Hormone Receptor Antagonist Modulates Lung Inflammation and Fibrosis due to Bleomycin.
Zhang C; Cai R; Lazerson A; Delcroix G; Wangpaichitr M; Mirsaeidi M; Griswold AJ; Schally AV; Jackson RM
Lung; 2019 Oct; 197(5):541-549. PubMed ID: 31392398
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways.
Ma WH; Li M; Ma HF; Li W; Liu L; Yin Y; Zhou XM; Hou G
Life Sci; 2020 Jan; 241():117139. PubMed ID: 31809714
[TBL] [Abstract][Full Text] [Related]
15. Chrysin mitigates bleomycin-induced pulmonary fibrosis in rats through regulating inflammation, oxidative stress, and hypoxia.
Kseibati MO; Sharawy MH; Salem HA
Int Immunopharmacol; 2020 Dec; 89(Pt A):107011. PubMed ID: 33045575
[TBL] [Abstract][Full Text] [Related]
16. Role of histamine H
Sgambellone S; Febo M; Durante M; Marri S; Villano S; Bereshchenko O; Migliorati G; Masini E; Riccardi C; Bruscoli S; Lucarini L
Inflamm Res; 2023 Nov; 72(10-11):2037-2052. PubMed ID: 37815550
[TBL] [Abstract][Full Text] [Related]
17. Allergic inflammation is augmented via histamine H4 receptor activation: The role of natural killer cells in vitro and in vivo.
Ehling S; Roßbach K; Dunston SM; Stark H; Bäumer W
J Dermatol Sci; 2016 Aug; 83(2):106-15. PubMed ID: 27155791
[TBL] [Abstract][Full Text] [Related]
18. Preventive and therapeutic effects of thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis.
Conte E; Fagone E; Gili E; Fruciano M; Iemmolo M; Pistorio MP; Impellizzeri D; Cordaro M; Cuzzocrea S; Vancheri C
Oncotarget; 2016 Jun; 7(23):33841-54. PubMed ID: 27029074
[TBL] [Abstract][Full Text] [Related]
19. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
[TBL] [Abstract][Full Text] [Related]
20. Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity.
Pini A; Shemesh R; Samuel CS; Bathgate RA; Zauberman A; Hermesh C; Wool A; Bani D; Rotman G
J Pharmacol Exp Ther; 2010 Dec; 335(3):589-99. PubMed ID: 20826567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
